KinderPharm

Exton, United States Founded: 2014 • Age: 12 yrs Acquired By Synteract
Pediatric CRO services for drug development and formulations are specialized.
Annual revenue - Latest available
Total funding $1.0M 1 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 5 Brand Intelligence

About KinderPharm

KinderPharm is a company based in Exton (United States) founded in 2014 was acquired by Synteract in November 2018. KinderPharm has raised $1 million across 1 funding round from investors including Synteract. KinderPharm operates in a competitive market with competitors including Paidion Research, SmartTots, Springs Medical Research and Auxiliis Pharma, among others.

  • Headquarter Exton, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $1 M (USD)

    in 1 rounds

  • Latest Funding Round
    $1 M (USD), Seed

    Aug 12, 2015

  • Investors
  • Employee Count
    Not available
  • Acquired by
    Synteract

    (Nov 15, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of KinderPharm

KinderPharm has successfully raised a total of $1M through 1 strategic funding round. The most recent funding activity was a Seed round of $1 million completed in August 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in KinderPharm

KinderPharm has secured backing from 1 investor. Prominent investors backing the company include Synteract.

All
Investor Description Founded Year Domain Location
Full-service CRO operations are conducted across more than 60 countries.
Locked Locked Locked
Premium access

Investor details for KinderPharm

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by KinderPharm

Investments
Premium access

Investment portfolio details for KinderPharm

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - KinderPharm

Premium access

Detailed financials for KinderPharm

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Kinderpharm Comparisons

KinderPharm Primary company
Description
Pediatric CRO services for drug development and formulations...
Location
Exton, United States
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for KinderPharm

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of KinderPharm

KinderPharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Paidion Research, SmartTots, Springs Medical Research and Auxiliis Pharma, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Specializes in CRO services focused on pediatric clinical research.
Locked Locked Locked
Specializes as a CRO providing paediatric drug development services.
Locked Locked Locked
Offers primary care, medical consultations, and clinical research in Miami.
Locked Locked Locked
Provides clinical trial services, biometrics, and medical device development expertise.
Premium access

Detailed competitors of KinderPharm

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Kinderpharm

Premium access

Complete news archive for KinderPharm

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about KinderPharm

KinderPharm was founded in 2014 and raised its 1st funding round 1 year after it was founded.

KinderPharm is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.

KinderPharm is a funded company, having raised a total of $1M across 1 funding round to date.

KinderPharm was established in 2014 in Exton, United States, as a specialized CRO in the pharmaceutical sector. Focus is placed on pediatric drug development, with operations encompassing the design, management, and execution of various aspects. These include age-appropriate formulations, juvenile toxicology studies, dose extrapolation methods, population pharmacokinetics with sparse sampling, global clinical trials, and regulatory submissions. Expertise is directed exclusively toward pediatric products.

KinderPharm's top competitors include Paidion Research, SmartTots and Springs Medical Research.

KinderPharm has 1 investor. Key investors include Synteract.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available